ABSTRACT
In the UK, National Institute for Clinical Excellence (NICE) guidelines for treating panic disorder and GAD are due to be published in late 2004.
Benzodiazepines
BDZs act at the GABAA-BDZ receptor complex (see Chapter 1 and Fig. 6.1).
In the UK, National Institute for Clinical Excellence (NICE) guidelines for treating panic disorder and GAD are due to be published in late 2004.
Benzodiazepines
BDZs act at the GABAA-BDZ receptor complex (see Chapter 1 and Fig. 6.1).